LFVN - Lifevantage Corp


4.8
0.280   5.833%

Share volume: 276,856
Last Updated: 03-03-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.15%

PREVIOUS CLOSE
CHG
CHG%

$4.52
0.28
0.06%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 06-30-2025 09-30-2025 12-31-2025
Fiscal Quarter Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Report Date 05-02-2024 10-29-2024 10-29-2024 02-05-2025 05-06-2025 09-04-2025 11-04-2025 02-04-2026
Cash flow financing -2.464 M -2.741 M -1.828 M -1.400 M -1.127 M -3.243 M -4.297 M -738.000 K
Other financing cash flows -233.000 K -310.000 K -347.000 K -898.000 K -771.000 K -648.000 K -3.284 M -164.000 K
Cash flow 338.000 K -437.000 K -2.756 M 7.307 M 770.000 K -2.408 M -7.041 M -2.774 M
Net income 1.659 M 1.305 M 1.826 M 2.550 M 3.470 M 1.959 M 2.155 M 276.000 K
Depreciation 895.000 K 806.000 K 797.000 K 806.000 K 803.000 K 750.000 K 610.000 K 752.000 K
Changes in inventories 0.000 0.000 1.503 M 0.000 0.000 0.000 29.000 K 0.000
Changes in receivables 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Investing Cashflow -291.000 K -278.000 K -345.000 K -492.000 K -331.000 K -199.000 K -439.000 K -4.827 M
Net Borrowings 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Investing Activity Other 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Dividends Paid -448.000 K -503.000 K -500.000 K -502.000 K -503.000 K -562.000 K -571.000 K -575.000 K
Exchange Rate Effect 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Capital Expenditures 291.000 K 278.000 K 345.000 K 492.000 K 331.000 K 199.000 K 439.000 K 1.084 M
Cash Change 46.000 K -491.000 K -2.290 M 6.999 M 874.000 K -2.268 M -7.110 M -2.910 M